Data / Drug companies / Paroxetine hydrochloride
Paroxetine hydrochloride: 16 companies and 51 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Paroxetine hydrochloride is listed in the FDA National Drug Code Directory by 16 companies, with 51 products in commercial distribution. 41 of the products (80.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, film coated, extended release; suspension, and the newest product started marketing on March 5, 2026.
The request: Get every company that lists paroxetine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 51
- Generic (ANDA) products
- 41 (80.4%)
- Application numbers
- 8
- Routes
- Oral
- Brand names
- Paroxetine, Paroxetine, Paxil, Paxil CR
- openFDA record search
- api.fda.gov
Companies that list paroxetine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Apotex Corp. | 14 | tablet, film coated; tablet, film coated, extended release | New drug applications (NDA) | August 9, 2019 |
| Aurobindo Pharma Limited | 4 | tablet, film coated | Generic drugs (ANDA) | July 25, 2007 |
| Golden State Medical Supply, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | July 30, 2003 |
| NorthStar Rx LLC | 4 | tablet, film coated | Generic drugs (ANDA) | July 25, 2007 |
| Oxford Pharmaceuticals, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | November 14, 2022 |
| Zydus Lifesciences Limited | 4 | tablet, film coated | Generic drugs (ANDA) | April 13, 2007 |
| Lannett Company, Inc. | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | October 31, 2014 |
| Remedyrepack Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 8, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | September 8, 2003 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | September 8, 2003 |
| Preferred Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | April 13, 2007 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 30, 2003 |
| Bryant Ranch Prepack | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | October 31, 2014 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | November 14, 2022 |
| Camber Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | March 5, 2026 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 8, 2003 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 40 | 78.4% |
| Tablet, film coated, extended release | 10 | 19.6% |
| Suspension | 1 | 2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 41 | 80.4% |
| New drug applications (NDA) | 7 | 13.7% |
| Authorized generics (NDA) | 3 | 5.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 51 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.